WHO lobbies EU lawmakers against watering down alcohol cancer risk on 07/11/23
In an unprecedented move, the World Health Organization (WHO) sent a letter –obtained by Euractiv– to MEPs ahead of a crucial European Parliament’s vote expressing “increasing concern” on the state of play of the EU’s flagship Beating Cancer plan due to a “scientifically inaccurate and worrisome” wording on alcohol use. Young Dutch designer shows EU pharma the way in climate change fight on 06/11/23
With the Dutch healthcare sector responsible for 7% of all greenhouse gas emissions, pharmaceutical companies are joining the fight against climate change. On such an important mission, it’s all hands on deck and no one is too young to contribute. Sweden expands use of spray that reverses opoid overdose on 06/11/23
The Swedish government says it will move quickly to make naloxone, a spray that rapidly reverses an opioid overdose, widely available outside the healthcare system in order to save more lives. In France, gene therapy suffers from weak economic model on 03/11/23
France is one of the most advanced countries for gene therapies, both in Europe and worldwide. However, the lack of funding and the economic fragility of the sector are holding back the development of these innovative treatments. Cancer therapy value assessments need renewal to keep pace with rapid scientific innovation [Promoted content] on 03/11/23
Innovation in science is advancing cancer care through early detection and treatment, bringing significant economic benefits to healthcare systems. Future incentives for innovation, particularly early detection and treatment approaches, must be recognised so that patients can benefit from this progress. No decision in sight on whether to extend COVID-19 vaccine waiver on 02/11/23
No progress was made in discussions on whether to extend the COVID-19 vaccine waiver to include diagnostics and therapeutics at the latest meeting of trade officials. Patient access to Slovak market’s most expensive drug remains blurry on 02/11/23
In Slovakia, a dispute has resurfaced over who should foot the bill for highly expensive drugs - with patients and their caregivers struggling under the unclear regulatory system. Navigating care pathways for stroke survivors across the EU on 02/11/23
As the focus across the EU is usually on the prevention of stroke, post-stroke survivors are often left behind, without no national plans that take into account the need for a continuation of treatment after their discharge from medical institutions. The lack of care for stroke survivors comes at a great cost on 02/11/23
Most European countries lack a plan for how to care for stroke survivors, missing out on an opportunity to ease a big burden weighing on already stretched health systems. Hazardous substances in tattoo inks still exceed EU limits, Swedish agency warns on 02/11/23
Tattoo inks still contain potentially carcinogenic and allergenic substances in forbidden concentrations despite the introduction of an EU regulation in January 2022, according to an analysis by the Swedish Medical Products Agency.
|
|
